SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-056349
Filing Date
2017-10-06
Accepted
2017-10-06 19:26:40
Documents
1
Period of Report
2017-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3210
  Complete submission text file 0001209191-17-056349.txt   4554
Mailing Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080
Business Address
Barron Hal (Reporting) CIK: 0001418677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 171128350

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)